Gabapentin for back pain
Pro Research Analysisby 
Searched over 200M research papers
Gabapentin for Chronic Low Back Pain: Effectiveness and Safety
Effectiveness of Gabapentin for Chronic Low Back Pain
Multiple studies have evaluated gabapentin for chronic low back pain (CLBP), both with and without radiating symptoms. The majority of high-quality evidence shows that gabapentin does not provide significant pain relief compared to placebo or other standard treatments. Randomized controlled trials and systematic reviews found minimal or no improvement in pain intensity or disability scores when gabapentin was used for CLBP, regardless of whether the pain radiated into the legs or not 1269. In direct comparisons, other analgesics such as amitriptyline, tramadol/acetaminophen, and celecoxib were found to be more effective than gabapentin or pregabalin 16.
However, one observational study reported that gabapentin reduced pain scores and improved sleep quality in patients with low back pain, with a majority of patients expressing satisfaction with the treatment . This finding contrasts with the larger body of evidence from randomized trials, which generally do not support gabapentin’s effectiveness for this condition 1269.
Gabapentin for Neuropathic Back Pain and Failed Back Surgery Syndrome
Gabapentin is established as a treatment for neuropathic pain, and some guidelines recommend it for neuropathic components of back pain 510. In patients with failed back surgery syndrome (FBSS), which often involves neuropathic pain, both gabapentin and pregabalin were effective in reducing pain, though pregabalin was superior . This suggests gabapentin may have a role in specific cases of neuropathic back pain, but not for nonspecific or non-neuropathic CLBP 169.
Safety and Adverse Effects of Gabapentin
Gabapentin is associated with a higher risk of adverse effects compared to placebo. Common side effects include dizziness, fatigue, cognitive difficulties, and visual disturbances 159. The number needed to harm for these side effects is relatively low, meaning adverse events are not uncommon . While no serious adverse events or hospitalizations were reported in the studies, the risk of side effects and potential for misuse have led to increased regulatory scrutiny and reclassification of gabapentinoids in some countries 158.
Current Guidelines and Recommendations
Recent guidelines and systematic reviews advise caution in prescribing gabapentin for chronic low back pain, especially when there is no clear neuropathic component 1589. The evidence supporting its use is limited and of low quality, and the risk of adverse effects is significant. There is a consensus that more high-quality research is needed, but current data do not support routine use of gabapentin for nonspecific CLBP 1456+2 MORE.
Conclusion
The current evidence does not support the use of gabapentin for chronic low back pain without a neuropathic component, as it does not provide meaningful pain relief and carries a risk of adverse effects. Gabapentin may be considered for neuropathic back pain or specific conditions like failed back surgery syndrome, but even in these cases, alternative treatments may be more effective. Clinicians should exercise caution and consider the risk-benefit profile before prescribing gabapentin for back pain.
Sources and full results
Most relevant research papers on this topic